한글목차

세계 디지털 당뇨병 관리 시장의 미래는 병원, 재택 환경, 진단 센터 시장에서의 기회로 인해 유망합니다. 세계 디지털 당뇨병 관리 시장은 2025년부터 2031년까지 10.8%의 CAGR로 2031년까지 약 344억 달러에 달할 것으로 예상됩니다. 이 시장의 주요 촉진요인은 당뇨병 유병률 증가, 기술 발전, 당뇨병 관리를 위한 클라우드 기반 기업용 솔루션의 채택 확대 등입니다.

• Lucintel의 예측에 따르면, 당뇨병 관리를 위한 인슐린 자가 투여를 위한 스마트 인슐린 펌프와 인슐린 패치의 채택이 확대됨에 따라 유형별로는 웨어러블 디바이스가 예측 기간 동안 큰 부문을 차지할 것으로 보입니다.
• 최종 용도별로는 원격 환자 모니터링을 위한 디지털 기술 채택이 증가하고 병원 내 첨단 디지털 당뇨병 관리 도구의 손쉬운 사용으로 인해 병원이 가장 큰 시장으로 성장할 것으로 예상됩니다.
• 지역별로는 북미가 커넥티드 당뇨 관리 기기에 대한 수요 증가, 당뇨 관리 및 비만 앱 채택 급증, 자가 당뇨 관리 인식 증가로 인해 예측 기간 동안 가장 높은 성장세를 보일 것으로 예상됩니다.

디지털 당뇨병 관리 시장의 전략적 성장 기회

기술 중심의 발전과 소비자 행동의 변화는 디지털 당뇨병 관리 시장의 성장 기회를 창출하고 있습니다. 개발의 중점 분야가 분명해지고 있으며, 주요 응용 분야는 잠재적으로 변화를 가져올 수 있는 잠재력을 가지고 있습니다. 이 보고서에서는 고려해야 할 5가지 전략 옵션을 제시합니다.

• 원격의료 및 원격 모니터링 솔루션의 확대 : 성장의 기회는 원격의료 및 원격 모니터링 솔루션의 확대에 있습니다. 이러한 기기를 통해 의사는 가상 방문을 할 수 있어 환자의 의료 서비스 접근성을 높일 수 있습니다. 원격 당뇨병 관리를 지원하고 환자 참여를 강화하는 디지털 도구의 수용 확대는 더 많은 원격의료가 사용됨에 따라 관찰될 것입니다.
• 웨어러블 기술의 혁신 : 첨단 지속형 혈당 측정기(CGM)와 스마트 인슐린 펜은 웨어러블 기술의 큰 발전으로 새로운 성장 기회를 가져다 줄 것입니다. 웨어러블 기기와 연동되는 모바일 애플리케이션은 당뇨병 치료 결과를 개선할 수 있는 잠재력을 가지고 있습니다. 미래의 웨어러블 기기는 더 향상된 기능과 정확성을 포함할 수 있으며, 이는 환자와 의료진에게 더 나은 치료 결과를 가져다 줄 수 있습니다.
• 개인화된 당뇨병 관리 시스템 : 당뇨병 치료를 위한 AI 기반 개인화 시스템 개발은 현실적인 가능성입니다. 이러한 솔루션은 개인별 정보를 기반으로 정확한 제안을 통해 더 나은 질병 관리를 가능하게 할 수 있습니다. 특정 환자의 문제를 해결함으로써 기업은 전반적인 관리와 건강 결과를 개선할 수 있습니다.
• 디지털 당뇨병 교육 프로그램의 성장 : 이는 디지털 당뇨병 교육 프로그램에 큰 성장 기회가 될 수 있습니다. 이러한 프로그램은 환자들에게 더 나은 질환 관리에 필요한 귀중한 정보, 리소스, 지원을 제공할 수 있습니다. 인터랙티브하고 매력적인 컨텐츠를 도입함으로써 디지털 교육 프로그램은 환자들의 지식을 향상시키고 당뇨병 치료를 개선하는 데 도움이 될 수 있습니다.

디지털 당뇨병 관리 시장의 전략적 성장 기회는 통합 강화, 원격진료 확대, 개인화된 솔루션을 위한 기술 활용에 초점을 맞추고 있습니다. 통합 플랫폼의 개발, 웨어러블 기술의 발전, 디지털 교육에 대한 투자는 당뇨병 관리를 크게 개선할 수 있습니다. 접근이 용이하고 개인화된, 보다 효과적인 치료의 제공은 환자와 의료 서비스 제공자 모두에게 이익을 가져다 주며, 동시에 이 시장을 재편할 수 있습니다.

디지털 당뇨병 관리 시장 촉진요인 및 과제

디지털 당뇨병 관리 시장의 성장은 그 발전에 영향을 미치는 다양한 요인과 과제에 의해 좌우됩니다. 시장 상황은 기술적 진보, 경제적 요인, 규제 상황에 의해 형성됩니다. 이에 본 보고서에서는 시장에 영향을 미치는 주요 촉진요인 및 과제에 대한 분석을 소개합니다.

디지털 당뇨병 관리 시장의 촉진요인은 다음과 같습니다:

• 기술 발전 : 디지털 당뇨병 관리 시장은 개선된 CGM, AI 분석, 웨어러블 기기 등 다양한 기술 발전에 힘입어 성장하고 있습니다. 이러한 발전은 혈당 모니터링, 데이터 정확도, 개인별 맞춤 치료를 향상시켜 환자 결과를 개선할 수 있습니다.
• 원격의료의 채택 증가 : 원격의료 서비스의 보급으로 당뇨병 치료에 대한 접근성이 확대되고 있습니다. 원격진료 및 모니터링 옵션을 통해 환자들은 적시에 도움을 받을 수 있어 전반적인 관리와 순응도를 향상시킬 수 있습니다.
• 환자 참여에 대한 관심 증가 : 환자의 자가 관리를 촉진하고 참여를 향상시키는 디지털 플랫폼에 대한 관심이 높아지고 있습니다. 인터랙티브 애플리케이션과 온라인 코칭 프로그램은 환자가 당뇨병 치료에 적극적으로 참여하도록 유도하여 처방된 치료 요법의 순응도를 높일 수 있습니다.

디지털 당뇨병 관리 시장의 과제는 다음과 같습니다:

• 데이터 프라이버시 및 보안 문제 : 디지털 당뇨병 관리에서 중요한 과제는 환자 데이터의 프라이버시 및 보안 보호입니다. 더 많은 건강 정보가 수집될수록 데이터 유출 및 무단 액세스에 대한 우려가 생겨 환자의 신뢰와 도입에 영향을 미칠 수 있습니다.
• 규제적 장애물 : 새로운 디지털 헬스 기술에 대한 규제 요건과 승인은 까다롭습니다. 규제 장벽은 혁신적인 솔루션의 도입을 지연시키고 시장 성장을 저해할 수 있습니다.
• 통합 및 상호운용성 문제 : 새로운 디지털 툴을 기존 의료 시스템에 통합하고 데이터의 상호운용성을 확보하는 데 어려움이 있습니다. 표준화 부족과 호환성 문제는 디지털 당뇨병 관리 솔루션의 원활한 사용을 방해할 수 있습니다.

디지털 당뇨병 관리 시장의 성장은 여러 가지 촉진요인과 함께 몇 가지 도전 과제에 의해 형성되고 있습니다. 기술 발전, 원격의료 서비스 도입 확대, 환자 참여의 중요성이 주요 촉진요인인 반면, 데이터 프라이버시 우려, 규제 장애물, 통합의 딜레마 등이 주요 도전과제로 작용하고 있습니다. 디지털 당뇨병 관리의 발전을 촉진하고 당뇨병 환자 치료를 개선하기 위해서는 이러한 병목현상을 극복하고 이러한 촉진요인이 가져다주는 기회를 활용해야 합니다.

목차

제1장 주요 요약

제2장 세계의 디지털 당뇨병 관리 시장 : 시장 역학

• 소개, 배경, 분류
• 공급망
• 업계 성장 촉진요인과 과제

제3장 시장 동향과 예측 분석(2019-2031년)

• 거시경제 동향(2019-2024년)과 예측(2025-2031년)
• 세계의 디지털 당뇨병 관리 시장 동향(2019-2024년)과 예측(2025-2031년)
• 세계의 디지털 당뇨병 관리 시장 : 제품별
  • 스마트 혈당 미터
  • 연속 혈당 모니터링 시스템
  • 스마트 인슐린 펜
  • 스마트 인슐린 펌프
  • 앱
• 세계의 디지털 당뇨병 관리 시장 : 종류별
  • 웨어러블 디바이스
  • 핸드헬드 디바이스
• 세계의 디지털 당뇨병 관리 시장 : 최종 용도별
  • 병원
  • 재택의료
  • 진단 센터

제4장 지역별 시장 동향과 예측 분석(2019-2031년)

• 세계의 디지털 당뇨병 관리 시장 : 지역별
• 북미의 디지털 당뇨병 관리 시장
• 유럽의 디지털 당뇨병 관리 시장
• 아시아태평양의 디지털 당뇨병 관리 시장
• 기타 지역의 디지털 당뇨병 관리 시장

제5장 경쟁 분석

• 제품 포트폴리오 분석
• 운영 통합
• Porter's Five Forces 분석

제6장 성장 기회와 전략 분석

• 성장 기회 분석
  • 세계의 디지털 당뇨병 관리 시장 성장 기회 : 제품별
  • 세계의 디지털 당뇨병 관리 시장 성장 기회 : 종류별
  • 세계의 디지털 당뇨병 관리 시장 성장 기회 : 최종 용도별
  • 세계의 디지털 당뇨병 관리 시장 성장 기회 : 지역별
• 세계의 디지털 당뇨병 관리 시장 최신 동향
• 전략적 분석
  • 신제품 개발
  • 세계의 디지털 당뇨병 관리 시장 생산능력 확대
  • 세계의 디지털 당뇨병 관리 시장 기업 인수합병(M&A), 합작투자
  • 인증과 라이선싱

제7장 주요 기업 개요

• Abbott Laboratories
• Medtronic
• F. Hoffmann-La Roche
• Bayer
• Lifescan
• Dexcom
• Sanofi
• Insulet Corporation
• Ascensia Diabetes Care Holdings
• B Braun Melsungen

영문목차

The future of the global digital diabetes management market looks promising with opportunities in the hospital, home setting, and diagnostic center markets. The global digital diabetes management market is expected to reach an estimated $34.4 billion by 2031 with a CAGR of 10.8% from 2025 to 2031. The major drivers for this market are the increasing prevalence of diabetes, technological advancements, and the growing adoption of cloud-based enterprise solutions for diabetes management.

• Lucintel forecasts that, within the type category, wearable devices will remain the larger segment over the forecast period due to the growing adoption of smart insulin pumps and insulin patches for self-insulin delivery for the management of diabetes.
• Within the end use category, hospitals will remain the largest segment due to the increasing adoption of digital technologies for remote patient monitoring and the easy availability of advanced digital diabetes management tools in hospitals.
• In terms of regions, North America is expected to witness the highest growth over the forecast period due to the increasing demand for connected diabetes management devices, surging adoption of diabetes management and obesity apps, and growing awareness of self-diabetes management in the region.

Gain valuable insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Digital Diabetes Management Market

The digital diabetes management market is evolving rapidly through various directions that will shape its future. Numerous innovative solutions and advanced technology integration have led to personalized and efficient approaches to managing diabetes.

• Artificial Intelligence Integration: Digital diabetes management tools are increasingly adopting artificial intelligence (AI). AI algorithms use data from continuous glucose monitors (CGMs) and other sources to offer personalized insights and recommendations. This development enhances prediction, allowing users to make better decisions regarding their diabetes management practices. AI-based tools are improving glucose prediction accuracy, thus enhancing overall disease control and patient outcomes.
• Growth of Wearable Technology: In digital diabetes management, wearable technology is becoming very popular, with examples including smart insulin pens and advanced CGMs. These wearables can monitor glucose levels in real time and deliver insulin automatically, thereby improving convenience and accuracy in managing diabetes. It is now simpler for individuals to monitor their sugar levels with the help of wearable technology, resulting in better patient involvement and improved health outcomes.
• Expansion of Telehealth Services: Diabetes care is being revolutionized by the expansion of telehealth services, which offer remote consultations and support. With digital platforms, patients can connect with healthcare providers without necessarily appearing in their offices, making the management of diabetes mellitus more accessible and convenient. This especially benefits those in remote or underserved areas, who now have better access to specialized care and improved overall diabetes management.
• Enhanced Data Interoperability: This trend is growing because it allows for seamless integration of diabetes management tools into electronic health records (EHRs) and other healthcare systems. It enables better coordination between patients and practitioners, facilitating more comprehensive and efficient care. Sharing enhanced data ensures that all members of the medical team always have the latest patient information, leading to better-informed decisions about treatment that result in improved patient outcomes.

The marketplace has been remodeled by these novel trends within digital diabetes care systems that embrace new technology and inventive solutions, thus improving patient welfare. Diabetes management is being drastically enhanced due to AI integration, wearable technology, telehealth services, data interoperability, and a focus on patient engagement. These trends aim to foster personalized accessibility and efficacy in managing diabetes, thereby significantly improving the health status of diabetes patients and changing the landscape of diabetes treatment.

Recent Developments in the Digital Diabetes Management Market

Recent developments in digital diabetes management have revolutionized diabetes monitoring and treatment. The application of advanced technologies such as wearable devices, mobile apps, and data analytics has led to better patient care and disease control. These improvements have enhanced real-time monitoring capabilities, personalized treatment plans, and increased overall patient involvement.

• Integration of Continuous Glucose Monitoring (CGM) Systems: The integration of continuous glucose monitoring (CGM) systems with mobile applications represents a significant advancement. CGMs provide real-time blood sugar readings that are sent to mobile apps for tracking purposes. With this development, patients can regularly check their blood sugar levels, enabling them to maintain better glycemic control and make more informed decisions about their care regimens. Seamless data sharing between CGMs and apps improves patient engagement and supports early interventions in diabetes.
• Dynamic Progress in Artificial Intelligence (AI) through Diabetic Care: Glucose data is analyzed and trends are predicted using artificial intelligence (AI). AI algorithms analyze CGM data and other sources to generate personalized suggestions or alerts. This technology enables better insulin dosing and more effective diabetes management by predicting glucose fluctuations before they occur. The overall treatment outcomes from AI in predicting and managing diabetes are improving, leading to more individualized care.
• Expansion of Telehealth Services: The expansion of telehealth services has changed how diabetes is managed by providing remote consultations and support. Patients can now consult medical practitioners without having to travel long distances, especially those who live in rural areas with limited access to health services. Telehealth platforms ensure continuous monitoring and timely check-ins, ensuring that patients receive the right support when it is most needed. This development improves accessibility and convenience for individuals managing diabetes.
• Increased Focus on Patient Engagement Platforms: Patient engagement platforms are becoming increasingly popular. Consequently, diabetes patients are being educated and empowered through interactive apps and digital coaching programs. These platforms have features that help monitor progress, set goals, and motivate users. As a result, patients are now adhering to treatment regimens, thereby enhancing their overall health.

The digital diabetes management market has recently undergone numerous changes that have made it more accurate and patient-friendly. Diabetes is monitored and managed differently today through combined glucose monitoring devices, AI-powered analytics, remote healthcare services, patient engagement systems, and smart insulin pens. Consequently, diabetic patients now have improved access to care, including real-time data provision, personalized recommendations, and better outcomes.

Strategic Growth Opportunities for Digital Diabetes Management Market

Technology-driven advancements and transforming consumer behavior have created opportunities for growth in the digital diabetes management market. Focused areas for development are becoming apparent, with key applications offering a potentially transformative experience. This article presents five strategic options to consider.

• Expansion of Telemedicine and Remote Monitoring Solutions: The opportunity for growth lies in expanding telehealth and remote monitoring solutions. These devices enable physicians to conduct virtual visits, thereby increasing access to healthcare services for patients. The increased acceptance of digital tools that support remote diabetes management and enhance patient involvement can be observed as more distance care is utilized.
• Innovation in Wearable Technology: Advanced continuous glucose monitors (CGMs) and smart insulin pens represent significant advancements in wearable technology that present new growth opportunities. Mobile applications that connect with wearable devices have the potential to improve diabetes treatment outcomes. Future wearables could include enhanced functionalities and increased accuracy, resulting in better outcomes for patients and providers.
• Personalized Diabetes Management Systems: Developing AI-based personalized systems for diabetes care is a viable possibility. Such solutions can offer accurate suggestions based on individual information, leading to better disease control. By addressing specific patient issues, companies can enhance overall management and health outcomes.
• Growth of Digital Diabetes Education Programs: This presents a significant growth opportunity for digital diabetes education programs. These programs can provide patients with valuable information, resources, and support necessary for better managing their condition. By incorporating interactive and engaging content, patient knowledge in digital education programs can be enhanced, leading to improved diabetes care.

Strategic growth opportunities in the digital diabetes management market focus on enhancing integration, expanding remote care, and leveraging technology for personalized solutions. The development of integrated platforms, advancements in wearable technology, and investments in digital education could lead to substantial improvements in diabetes management. More effective care offerings that are accessible and personalized can reshape this market while benefiting both patients and healthcare providers.

Digital Diabetes Management Market Driver and Challenges

The growth of the digital diabetes management market is influenced by various factors and challenges that impact its progress. The market landscape is shaped by technological advancements, economic factors, and regulatory considerations. Thus, this paper presents an analysis of major drivers and challenges affecting the market.

The factors driving the digital diabetes management market include:

• Technological Advancements: The digital diabetes management market is being driven by a range of technological advancements, including improved CGMs, AI analytics, and wearable devices. These developments boost glucose monitoring, data precision, and individualized care, thereby leading to better patient outcomes.
• Increased Adoption of Telehealth: The increasing uptake of telehealth services is widening access to diabetes treatment. Remote consultation and monitoring options are making it easier for patients to receive timely assistance, enhancing overall control and adherence.
• Growing Focus on Patient Engagement: There is an increasing focus on digital platforms that encourage patient self-management and improve engagement. Interactive applications and online coaching programs help individuals participate more actively in their diabetes care, resulting in greater compliance with prescribed treatment regimens.

Challenges in the digital diabetes management market include:

• Data Privacy and Security Concerns: A significant challenge in digital diabetes management is protecting the privacy and security of patient data. As more health information is collected, there are concerns about data breaches and unauthorized access, which can impact patient trust and adoption.
• Regulatory Hurdles: Navigating regulatory requirements and obtaining approvals for new digital health technologies can be difficult. Regulatory barriers may delay the introduction of innovative solutions and hinder market growth.
• Integration and Interoperability Issues: Challenges arise when integrating new digital tools into existing healthcare systems and ensuring data interoperability. Lack of standardization and compatibility issues may prevent the smooth use of digital diabetes care solutions.

Various drivers shape the growth of the digital diabetes management market, along with several challenges. Technological advancements, increased adoption of telehealth services, and a focus on patient engagement are its main drivers, while concerns over data privacy, regulatory hurdles, and integration dilemmas pose significant challenges. To foster progress in digital diabetes management and improve care for diabetic patients, we must overcome these bottlenecks and capitalize on the opportunities presented by these drivers.

List of Digital Diabetes Management Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies digital diabetes management companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the digital diabetes management companies profiled in this report include-

• Abbott Laboratories
• Medtronic
• F. Hoffmann-La Roche
• Bayer
• Lifescan
• Dexcom
• Sanofi
• Insulet Corporation
• Ascensia Diabetes Care Holdings
• B Braun Melsungen

Digital Diabetes Management by Segment

The study includes a forecast for the global digital diabetes management market by product, type, end use, and region

Digital Diabetes Management Market by Product [Analysis by Value from 2019 to 2031]:

• Smart Glucose Meter
• Continuous Blood Glucose Monitoring System
• Smart Insulin Pens
• Smart Insulin Pumps
• Apps

Digital Diabetes Management Market by Type [Analysis by Value from 2019 to 2031]:

• Wearable Devices
• Handheld Devices

Digital Diabetes Management Market by End Use [Analysis by Value from 2019 to 2031]:

• Hospitals
• Home settings
• Diagnostic Centers

Digital Diabetes Management Market by Region [Analysis by Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Digital Diabetes Management Market

Digital diabetes management has been experiencing significant recent advancements that have greatly influenced the approach to diabetes care globally. Patient monitoring, engagement, and treatment personalization are being enhanced by advanced technological integrations such as wearable devices, mobile apps, and artificial intelligence (AI). These innovations address the increasing need for efficient and user-friendly solutions for diabetes management, offering real-time data and insights to improve patient outcomes.

• United States: In the United States, there has been noticeable uptake of high-tech digital diabetes management platforms. For example, continuous glucose monitors (CGMs) can now be integrated with smartphone applications, enabling real-time glucose tracking and management. Moreover, analytics based on AI are improving predictive capabilities, facilitating personalized therapies. Teleservices, such as telehealth and digital diabetes coaching, have also grown, reinforcing proper disease control and improving patient relationships while increasing access to care.
• China: The expansion of mobile health (mHealth) applications and telemedicine is driving rapid growth in digital diabetes management in China. Local tech companies are designing sophisticated platforms that merge CGM data with health management apps, providing users with comprehensive diabetes control tools. Government initiatives have been implemented to promote the integration of digital health solutions into mainstream care delivery systems, enhancing access and encouraging widespread utilization of diabetes management technologies in urban and rural areas.
• Germany: Smart insulin pens and advanced CGMs have revolutionized digital diabetes management in Germany. The use of these devices has improved glucose monitoring accuracy and insulin delivery. Moreover, Germany emphasizes data interoperability to enable easy integration between EHRs and diabetes management tools. Consequently, this connection enhances coordination between medical practitioners and their clients, leading to better treatment outcomes for both patients who comply with prescribed medications and the physicians themselves.
• India: India has seen the expansion of digital diabetes management through affordable mobile applications and wearable technologies. To address the high prevalence of diabetes in India, these tools provide simple-to-use glucose monitoring and management solutions. In particular, the growth of telemedicine platforms is facilitating access to diabetes care in underserved and remote areas. Efforts are underway to boost digital literacy and integrate these innovations into conventional healthcare delivery systems.
• Japan: Through highly accurate CGMs and automated insulin delivery systems, Japan is advancing in digital diabetes management. The goal is to integrate these systems with national health databases to improve patient tracking and intervention efficiency. Moreover, Japan is exploring AI-driven predictive analytics and personalized diabetes interventions that will enhance clinical performance among patients and streamline healthcare services. Furthermore, more patient education avenues, such as online platforms, are now available for individuals managing this disease.

Features of the Global Digital Diabetes Management Market

Market Size Estimates: Digital diabetes management market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.

Segmentation Analysis: Digital diabetes management market size by product, type, end use, and region in terms of value ($B).

Regional Analysis: Digital diabetes management market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different products, types, end uses, and regions for the digital diabetes management market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the digital diabetes management market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the digital diabetes management market by product (smart glucose meter, continuous blood glucose monitoring system, smart insulin pens, smart insulin pumps, and apps), type (wearable devices and handheld devices), end use (hospitals, home settings, and diagnostic centers), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Digital Diabetes Management Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

• 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
• 3.2. Global Digital Diabetes Management Market Trends (2019-2024) and Forecast (2025-2031)
• 3.3: Global Digital Diabetes Management Market by Product
  • 3.3.1: Smart Glucose Meter
  • 3.3.2: Continuous Blood Glucose Monitoring System
  • 3.3.3: Smart Insulin Pens
  • 3.3.4: Smart Insulin Pumps
  • 3.3.5: Apps
• 3.4: Global Digital Diabetes Management Market by Type
  • 3.4.1: Wearable Devices
  • 3.4.2: Handheld Devices
• 3.5: Global Digital Diabetes Management Market by End Use
  • 3.5.1: Hospitals
  • 3.5.2: Home settings
  • 3.5.3: Diagnostic Centers

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

• 4.1: Global Digital Diabetes Management Market by Region
• 4.2: North American Digital Diabetes Management Market
  • 4.2.1: North American Digital Diabetes Management Market by Type: Wearable Devices and Handheld Devices
  • 4.2.2: North American Digital Diabetes Management Market by End Use: Hospitals, Home settings, and Diagnostic Centers
• 4.3: European Digital Diabetes Management Market
  • 4.3.1: European Digital Diabetes Management Market by Type: Wearable Devices and Handheld Devices
  • 4.3.2: European Digital Diabetes Management Market by End Use: Hospitals, Home settings, and Diagnostic Centers
• 4.4: APAC Digital Diabetes Management Market
  • 4.4.1: APAC Digital Diabetes Management Market by Type: Wearable Devices and Handheld Devices
  • 4.4.2: APAC Digital Diabetes Management Market by End Use: Hospitals, Home settings, and Diagnostic Centers
• 4.5: ROW Digital Diabetes Management Market
  • 4.5.1: ROW Digital Diabetes Management Market by Type: Wearable Devices and Handheld Devices
  • 4.5.2: ROW Digital Diabetes Management Market by End Use: Hospitals, Home settings, and Diagnostic Centers

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Digital Diabetes Management Market by Product
  • 6.1.2: Growth Opportunities for the Global Digital Diabetes Management Market by Type
  • 6.1.3: Growth Opportunities for the Global Digital Diabetes Management Market by End Use
  • 6.1.4: Growth Opportunities for the Global Digital Diabetes Management Market by Region
• 6.2: Emerging Trends in the Global Digital Diabetes Management Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Digital Diabetes Management Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Digital Diabetes Management Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Abbott Laboratories
• 7.2: Medtronic
• 7.3: F. Hoffmann-La Roche
• 7.4: Bayer
• 7.5: Lifescan
• 7.6: Dexcom
• 7.7: Sanofi
• 7.8: Insulet Corporation
• 7.9: Ascensia Diabetes Care Holdings
• 7.10: B Braun Melsungen